Life Sciences Solutions — Acquisitions
Business Segments · AcquisitionsThermo Fisher Scientific Life Sciences Solutions — Acquisitions remained flat by 0.0% to $525.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 8.7%, from $575.50M to $525.25M.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025
How to read this metric
Higher spending indicates an aggressive growth strategy, while lower spending may signal a focus on organic growth or debt reduction.
Detailed definition
The total capital deployed by the Life Sciences Solutions segment to purchase other companies or business units. This me...
Peer comparison
Standard for companies in the highly fragmented life sciences and diagnostics industry.
Metric ID:
tmo_segment_life_sciences_solutions_acquisitionsHistorical Data
2 years
| FY'24 | FY'25 | |
|---|---|---|
| Value | $2.30B | $2.10B |
| YoY Change | — | -8.7% |
Range$2.10B – $2.30B
Avg YoY Growth-8.7%
Median YoY Growth-8.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's life sciences solutions — acquisitions?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — acquisitions of $525.25M in Q4 2025.
- How has Thermo Fisher Scientific's life sciences solutions — acquisitions changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — acquisitions decreased by 8.7% year-over-year, from $575.50M to $525.25M.
- What does life sciences solutions — acquisitions mean?
- The total dollar amount spent on acquiring new businesses within the life sciences segment.